ArticleNPJ breast cancer2025

Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy.

Luca Mastrantoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.